Most sales organizations measure forecast accuracy as a single number: the percentage by which the final forecast was off from actual closed revenue. A 10% miss is considered decent. A 20% miss means the forecast model needs work. A 30% miss triggers board-level conversations about CRO credibility.
This is not a bad metric. But it's a lagging indicator. By the time you know you had a 20% miss, the quarter is over. The deals have closed or slipped. Nothing can be done. What you need are leading metrics — measurements that tell you, mid-quarter, whether your forecast is on track or systematically drifting from where it should be. Three metrics specifically have turned out to be genuinely predictive of quarter-end outcome, at least in our work with growing B2B sales teams.
Metric 1: Commit Conversion Rate Trailing Average
The most commonly tracked version of forecast accuracy looks at whether your total forecast number matched total close. But this hides a lot. You can hit your total number through a combination of commits that closed, commits that slipped (replaced by pipeline deals that accelerated), and pipeline deals that unexpectedly pulled in. The aggregate number looks fine, but your forecasting model was actually a mess.
A more informative metric is your commit-to-close conversion rate: of all the deals you put in Commit at the start of a given week (or the start of a given period), what percentage actually closed as forecasted? Track this as a trailing average over four quarters, and the number tells you something real about the quality of your Commit category.
For most sales organizations, a healthy commit conversion rate is somewhere between 75% and 90%. Below 75%, your Commit category is too loose — reps are committing deals that don't have the behavioral evidence to support that call, and the CRO needs to tighten the criteria. Above 90% over a sustained period, you might actually be too conservative — deals are being held in Best Case that could have been called Commit with appropriate evidence, which means you're under-representing your predictable revenue and potentially making conservative resource decisions as a result.
The metric also has directional value. If your trailing commit conversion rate is 82% and it's been stable for three quarters, your forecast model is working. If it drops to 65% in the current quarter by week six, that's an early signal that the Commit category has gotten sloppy — which means your end-of-quarter number is likely to be weaker than the forecast suggests, even before you know which specific deals will slip.
Metric 2: Signal-to-Stage Ratio Across the Active Pipeline
This metric requires signal data to calculate — which means most organizations can't currently measure it without additional tooling. But it's worth understanding conceptually because it captures something real that no pure-CRM metric can.
The signal-to-stage ratio compares a deal's behavioral health score (based on engagement signals like response latency, meeting attendance, stakeholder activity) to its CRM stage. Specifically, you're looking at whether the behavioral signals are consistent with the stage the deal is in, or whether there's a divergence.
A deal in "Proposal Sent" with strong engagement signals — champion responding quickly, new stakeholders appearing, economic buyer joined the last call — has a high signal-to-stage alignment. The behavioral evidence supports the stage claim. A deal in "Negotiation" where the champion has gone quiet, meeting attendance has dropped, and no communication has happened in two weeks has low signal-to-stage alignment. The stage label says "negotiation" but the behavioral evidence says "stall."
When you aggregate signal-to-stage alignment across your full active pipeline, you get a picture of whether your pipeline's stated stage composition reflects real deal health or whether you're carrying deals that have drifted from their stage labels. A pipeline where the aggregate signal-to-stage ratio is declining is a pipeline where forecast risk is building faster than stage progression suggests.
We track this as part of Valuevynt's pipeline health dashboard. The metric doesn't replace deal-level review, but it gives CROs a fast read on whether the pipeline is healthy in aggregate or whether there's a gap between how deals are classified and how they're actually behaving.
Metric 3: Forecast Call Direction Accuracy
This is the metric that most directly measures whether your forecasting methodology is working, and it's almost never explicitly tracked. Forecast call direction accuracy measures not whether your forecast number was right, but whether the directional calls you made during the quarter were right. Specifically: for deals where you made a call between Commit and Best Case, or between Best Case and Pipeline, how often did the deal end up on the side you called it?
Here's why this matters separately from overall accuracy. It's possible to have good overall accuracy because a large deal you put in Commit closed and covered for several slipped deals you also had in Commit. The aggregate number looks fine, but you made multiple incorrect directional calls that happened to cancel out. Your forecasting model was actually producing bad signal — you just got lucky on net.
Conversely, it's possible to have poor overall accuracy because a Best Case deal you were deliberately conservative about pulled in unexpectedly. Your forecast was "wrong" in the sense that it underestimated close, but your directional call on the specific deal was defensible based on the evidence at the time.
Forecast call direction accuracy separates model quality from luck. A forecaster whose directional calls are right 80% of the time, operating in a quarter with unusual macro volatility that caused several unexpected deals to slip, has a different credibility conversation than a forecaster whose directional calls are right 50% of the time and who happened to hit their number because of unexpected pull-ins.
How These Three Metrics Work Together
The three metrics function as a system rather than independently. Commit conversion rate is your macro-level model health indicator. Signal-to-stage ratio is your leading pipeline risk indicator. Forecast call direction accuracy is your model quality and process integrity indicator.
In a healthy forecasting environment, all three are stable and within expected ranges. When they diverge, the pattern of divergence tells you something specific.
If commit conversion rate drops while signal-to-stage alignment is also declining, you have a pipeline health problem — the deals in your Commit category are showing weak behavioral signals, and the lower conversion rate is the consequence. The fix is behavioral: investigate why engagement is dropping in your committed deals and address the issues at the deal level.
If commit conversion rate is dropping but signal-to-stage alignment is fine, you have a classification problem — reps are putting deals in Commit before the behavioral signals support that classification. The fix is methodological: tighten your Commit criteria and build a shared understanding of what behavioral evidence is required before a deal can be called Commit.
If forecast call direction accuracy is dropping independent of overall conversion rate, you have a process integrity problem — the people making the classification calls are doing so inconsistently, possibly because different managers apply different standards or because the criteria aren't well-defined. The fix is governance: standardize the classification criteria and build a feedback loop where forecast calls are reviewed against outcomes.
The Practical Constraint
I'll be direct about the limitation here. Commit conversion rate is trackable with basic CRM and spreadsheet work — most sales ops teams can implement it in a week. Forecast call direction accuracy requires slightly more infrastructure: a way to log the calls you make and compare them to outcomes, which not every ops team has in place.
Signal-to-stage ratio requires behavioral signal data — email and calendar activity processed into per-deal health scores. That's what we've built, and it's the hardest of the three to implement without dedicated tooling. But it's also the most forward-looking, which is why it tends to be the metric that surfaces problems earliest in the quarter.
The value of measuring forecast accuracy with leading indicators rather than lagging ones is that you get the chance to intervene. A CRO who sees commit conversion rate declining at week six still has four weeks to investigate the specific deals, have difficult pipeline conversations, and potentially move the number before the quarter closes. A CRO who learns they had a 20% miss when the books close has no such opportunity. Measurement without intervention is just better documentation of failure — and that's not what forecasting infrastructure is for.